| 24-950 |
Urvashi Bhagat v. United States Patent and Trademark Office, et al. |
Federal Circuit |
2025-03-05 |
Denied |
Response Waived |
constitutional-standards due-process expert-testimony innovation nutrition-arts patent-law |
Whether lower courts erred in prejudicing innovation in nutrition arts by failing to uphold constitutional standards for patent advancement and due pr… |
| 24-47 |
Return Mail, Inc. v. United States |
Federal Circuit |
2024-07-16 |
Denied |
|
35-usc-101 abstract-idea alice-corporation-v-cls-bank innovation judicial-interpretation patent patent-eligibility patent-law return-mail-inc-v-united-states-postal-service section-101 |
Whether the claimed invention is ineligible for patent protection under the abstract-idea exception to 35 U.S.C. §101 |
| 21-1093 |
PersonalWeb Technologies LLC v. Google LLC, et al. |
Federal Circuit |
2022-02-07 |
Denied |
Response Waived |
abstract-idea alice-corp-v-cls-bank computer-implemented-invention computer-implemented-inventions federal-circuit innovation patent-eligibility patent-law technical-field |
How should courts determine whether a patent for a computer-implemented invention is patent-eligible because it 'improve[s] the functioning of the com… |
| 20-1809 |
VoIP-Pal.com, Inc. v. Apple, Inc., et al. |
Federal Circuit |
2021-06-29 |
Denied |
|
35-usc-101 innovation innovation-incentives judicial-framework legal-uncertainty patent-act patent-eligibility patent-law patent-system statutory-interpretation subject-matter-eligibility |
What is the appropriate standard for determining patent-eligibility under 35 U.S.C. §101? |
| 20-1119 |
Amarin Pharma, Inc., et al. v. Hikma Pharmaceuticals USA Inc., et al. |
Federal Circuit |
2021-02-16 |
Denied |
Amici (3)Response RequestedResponse WaivedRelisted (2) |
35-usc-103 graham-factors graham-v-john-deere hindsight-bias innovation innovation-protection nonobviousness-indicia objective-indicia obviousness-standard patent patent-law |
Whether a court must consider objective indicia of nonobviousness together with the other factors bearing on an obviousness challenge before making an… |
| 20-604 |
InfoBionic, Inc. v. Cardionet, LLC, et al. |
Federal Circuit |
2020-11-05 |
Denied |
|
35-usc-101 abstract-idea federal-circuit innovation longstanding-human-practice patent-eligibility patent-monopoly statutory-interpretation |
Whether the Federal Circuit has properly narrowed the scope of the abstract idea exception under 35 U.S.C. § 101 |
| 19-1376 |
Algignis, Inc. v. Federal Energy Regulatory Commission |
District of Columbia |
2020-06-15 |
Denied |
Response Waived |
administrative-law administrative-state agency-jurisdiction catch-22 civil-rights environmental-law innovation innovation-barriers judicial-review private-enterprise regulatory-capture regulatory-risk standing standing-doctrine |
Do small, relatively unknown groups have standing to try to solve their own local environmental problems that the government has failed to solve? |
| 19-1103 |
INO Therapeutics LLC, et al. v. Praxair Distribution Inc., et al. |
Federal Circuit |
2020-03-10 |
Denied |
Response Waived |
35-usc-101 drug-administration due-process eligibility innovation medical-research medical-treatment method-of-treatment patent patent-eligibility patient-outcomes personalized-medicine section-101 selective-treatment |
Whether a method of treatment that requires doctors to selectively administer a drug to certain patients and not others to enhance patient outcomes is… |
| 19-1062 |
CJ CheilJedang Corp., et al. v. International Trade Commission, et al. |
Federal Circuit |
2020-02-26 |
Denied |
Amici (1) |
claim-amendment doctrine-of-equivalents festo-corp-v-shoketsu innovation patent-infringement patent-law prosecution-history-estoppel public-notice public-notice-function tangential-relation |
Whether, to avoid prosecution history estoppel under Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 'the rationale underlying the amendment' mus… |
| 19-832 |
Apple Inc. v. VirnetX Inc., et al. |
Federal Circuit |
2019-12-31 |
Denied |
Amici (3)Response RequestedResponse WaivedRelisted (2) |
apportionment apportionment-rule federal-circuit innovation license-valuation patent-damages patent-infringement patent-invalidation pending-litigation prior-licenses |
Whether the Federal Circuit's reliance on prior licenses to ascertain infringement damages, without satisfying apportionment rules, conflicts with thi… |
| 19-584 |
Nuvo Pharmaceuticals (Ireland) Designated Activity Company, et al. v. Dr. Reddy's Laboratories Inc., et al. |
Federal Circuit |
2019-11-04 |
Denied |
Response Waived |
35-usc-112 enablement federal-circuit innovation patent patent-law pharmaceutical pharmaceutical-composition prior-art written-description |
Whether the Federal Circuit erred by holding that, whenever the prior art teaches away from a pharmaceutical composition, the written description of a… |
| 19-521 |
ChargePoint, Inc. v. SemaConnect, Inc. |
Federal Circuit |
2019-10-22 |
Denied |
Amici (2) |
35-usc-101 abstract-idea alice-corp-v-cls-bank alice-v-cls-bank diamond-v-diehr innovation judicial-interpretation machine-or-process patent-eligibility patent-law section-101 |
Whether a patent claim to a new and useful improvement to a machine or process may be patent eligible even when it 'involves' or incorporates an abstr… |
| 19-522 |
Trading Technologies International, Inc. v. IBG LLC, et al. |
Federal Circuit |
2019-10-22 |
Denied |
|
abstract-idea civil-procedure computer-implemented-invention computer-implemented-inventions federal-circuit innovation patent-act patent-act-1952 patent-eligibility standing |
Whether computer-implemented inventions that provide useful user functionality but do not improve the basic functions of the computer itself are categ… |
| 19-353 |
Trading Technologies International, Inc. v. IBG LLC, et al. |
Federal Circuit |
2019-09-18 |
Denied |
Amici (2)Response Waived |
abstract-idea civil-procedure computer-implemented-invention computer-implemented-inventions federal-circuit innovation patent-act patent-act-1952 patent-eligibility standing |
Whether computer-implemented inventions that provide useful user functionality but do not improve the basic functions of the computer itself are categ… |
| 18-127 |
Amgen Inc., et al. v. Sanofi, et al. |
Federal Circuit |
2018-07-27 |
Denied |
Amici (1)Response RequestedRelisted (2) |
35-usc-112 biotechnology enablement federal-circuit innovation patent-law possession statutory-interpretation written-description |
Whether the standard for determining the adequacy of the 'written description of the invention' should be as the statute says—that the description mus… |